Innovating the Go-to-Market Model in Asia
PharmExec
JANUARY 11, 2023
An ecosystem perspective is the first step.
PharmExec
JANUARY 11, 2023
An ecosystem perspective is the first step.
PM360
DECEMBER 20, 2023
Given China’s status as the world’s second most populous nation and an economic powerhouse, it represents both a monumental market opportunity and a dynamic arena of challenges for pharmaceutical products. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Evolve Your Success
OCTOBER 24, 2023
Sean breaks down the acronym, demystifying its meaning while sharing his transition from a lab manager to holding the role of Vice President of Global Sales and Marketing. You’re going to have to read this. OEM Sales is about creating solutions to win customers and making an impact, one deal at a time. Tune in now! find that out.
PM360
SEPTEMBER 7, 2023
Furthermore, the rise of the Black Lives Matter movement at the time forced organizations in all industries to take a closer look at their DE&I efforts and inspired some to do better and go beyond attempts that often only paid lip service to improving diversity. years, respectively) compared to White people (76.4)
pharmaphorum
SEPTEMBER 23, 2022
But what underlies all his work is a passion for global health equity, and for using the tools of health innovation and digital health to improve access to care for all countries. Tony Estrella is many things – a podcast host, a novelist, a digital health strategist, and a member of the Frontiers Health Steering Committee, to name a few.
pharmaphorum
DECEMBER 14, 2022
As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and life sciences companies that drive healthcare innovation and improve patient experiences. Introducing Angelini Ventures.
Cadensee
OCTOBER 19, 2021
Yotam Drechsler is CEO and Yaron Segal is CINO (Chief Innovation Officer) of BrainQ Technologies. 07:14 What is the difference between being an intrapreneur that innovates within an organization, and an entrepreneur? 20:27 Obviously the US market is very interesting, why aren’t you creating a product for the German market?
Let's personalize your content